Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with either atypical endometrial hyperplasia (abnormal cells in the lining of the uterus) or early-stage, slow-growing uterine cancer (Grade 1), confirmed by a procedure called a hysteroscopy, with no sign that the cancer has grown into the muscle wall of the uterus
- People whose scans (MRI, CT, or ultrasound) show no signs that the condition has spread outside the uterus
- People who wish to keep their uterus or preserve their ability to have children
- People who are willing and able to follow the treatment plan and attend regular follow-up appointments
Who may not be able to join:
- People who have liver disease, a liver tumour (whether cancerous or not), or reduced kidney function
- People who are pregnant or who may be pregnant
- People who have been diagnosed with any cancer affecting the reproductive system
- People who have had a serious condition such as a stroke or heart attack, or who have a history of blood clots
- People who are allergic to, or cannot safely take, the medications MPA or MA (types of hormone therapy)
- People who have other medical reasons affecting their reproductive function (confirm with trial site)
- People who prefer to have their uterus surgically removed or who want a different type of treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 8601088324383
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
sensitivity; accuracy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.